Payment overview · 2025
General Payments
4 reported records · 3 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Internal Medicine · TUCSON, AZ · NPI 1538117536
Verified facts
CMS Open Payments records show Charles S Kaplan, MD received $101.40 in general payments during 2025 across 4 reported records.
Ferring Pharmaceuticals Inc. accounted for 46.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Gemtesa.
Sumitomo Pharma America, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported GEMTESA as an associated drug or biological on 61692 records involving 22152 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Gemtesa by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
4 reported records · 3 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Ferring Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $47.32 | 46.7% | 2 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $29.20 | 28.8% | 1 | 2025 |
| Sumitomo Pharma America, Inc. | Unresolved — no canonical attribution shown | $24.88 | 24.5% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $101.40 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| ADSTILADRIN Normalized: adstiladrin |
Biological | Ferring Pharmaceuticals Inc. | $47.32 | 2 | 2025 |
Source payment records
|
|||||
| WATCHMAN FLX Normalized: watchman flx |
Device | Boston Scientific Corporation | $29.20 | 1 | 2025 |
Source payment records
|
|||||
| GEMTESA Normalized: gemtesa |
Drug | Sumitomo Pharma America, Inc. | $24.88 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| GEMTESA gemtesa |
2025 | Gemtesa | 2024 | 11 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Sumitomo Pharma America, Inc. Exact reporting entity; no affiliate inference |
2025 | GEMTESA open payments reported associated product |
CMS Open Payments — General Payments 61692 supporting records · 22152 recipient NPIs · example record 1176593503 |
Gemtesa · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 871 | 239 |
| Atorvastatin Calcium | Atorvastatin Calcium | 595 | 170 |
| Lisinopril | Lisinopril | 544 | 162 |
| Gabapentin | Gabapentin | 537 | 143 |
| Amlodipine Besylate | Amlodipine Besylate | 532 | 157 |
| Losartan Potassium | Losartan Potassium | 420 | 126 |
| Metformin Hcl | Metformin Hcl | 381 | 122 |
| Simvastatin | Simvastatin | 381 | 103 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 346 | 102 |
| Metoprolol Succinate | Metoprolol Succinate | 322 | 92 |
| Potassium Chloride | Potassium Chloride | 296 | 90 |
| Oxycodone Hcl | Oxycodone Hcl | 283 | 45 |
| Omeprazole | Omeprazole | 280 | 92 |
| Pantoprazole Sodium | Pantoprazole Sodium | 244 | 72 |
| Tamsulosin Hcl | Tamsulosin Hcl | 232 | 71 |
| Atenolol | Atenolol | 217 | 60 |
| Allopurinol | Allopurinol | 216 | 61 |
| Furosemide | Furosemide | 215 | 67 |
| Hydrochlorothiazide | Hydrochlorothiazide | 215 | 65 |
| Montelukast Sodium | Montelukast Sodium | 198 | 53 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 197 | 70 |
| Trazodone Hcl | Trazodone Hcl | 190 | 45 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 180 | 35 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 163 | 21 |
| Alprazolam | Alprazolam | 144 | 29 |
| Famotidine | Famotidine | 143 | 43 |
| Tramadol Hcl | Tramadol Hcl | 138 | 36 |
| Pravastatin Sodium | Pravastatin Sodium | 135 | 42 |
| Meloxicam | Meloxicam | 130 | 42 |
| Zolpidem Tartrate | Zolpidem Tartrate | 123 | 28 |
| Lorazepam | Lorazepam | 121 | 29 |
| Duloxetine Hcl | Duloxetine Hcl | 113 | 33 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 108 | 33 |
| Eliquis | Apixaban | 101 | 28 |
| Escitalopram Oxalate | Escitalopram Oxalate | 99 | 33 |
| Acyclovir | Acyclovir | 95 | 25 |
| Diazepam | Diazepam | 95 | 19 |
| Ezetimibe | Ezetimibe | 94 | 24 |
| Morphine Sulfate Er | Morphine Sulfate | 90 | suppressed |
| Celecoxib | Celecoxib | 89 | 25 |
| Tizanidine Hcl | Tizanidine Hcl | 88 | 23 |
| Jardiance | Empagliflozin | 86 | 24 |
| Lovastatin | Lovastatin | 86 | 25 |
| Azithromycin | Azithromycin | 85 | 65 |
| Fluticasone Propionate | Fluticasone Propionate | 84 | 34 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 83 | 28 |
| Fluoxetine Hcl | Fluoxetine Hcl | 83 | 20 |
| Mirtazapine | Mirtazapine | 80 | 24 |
| Ibuprofen | Ibuprofen | 79 | 22 |
| Clopidogrel | Clopidogrel Bisulfate | 78 | 23 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 76 | 38 |
| Spironolactone | Spironolactone | 75 | 22 |
| Amitriptyline Hcl | Amitriptyline Hcl | 74 | 13 |
| Metoprolol Tartrate | Metoprolol Tartrate | 73 | 26 |
| Ondansetron Hcl | Ondansetron Hcl | 71 | 23 |
| Sumatriptan Succinate | Sumatriptan Succinate | 69 | 14 |
| Prednisone | Prednisone | 68 | 22 |
| Carvedilol | Carvedilol | 66 | 20 |
| Donepezil Hcl | Donepezil Hcl | 66 | 22 |
| Methocarbamol | Methocarbamol | 66 | 23 |
| Alendronate Sodium | Alendronate Sodium | 64 | 21 |
| Sertraline Hcl | Sertraline Hcl | 64 | 22 |
| Temazepam | Temazepam | 62 | 12 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 60 | 19 |
| Buspirone Hcl | Buspirone Hcl | 59 | 11 |
| Finasteride | Finasteride | 58 | 16 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 56 | 16 |
| Warfarin Sodium | Warfarin Sodium | 55 | 14 |
| Diclofenac Sodium | Diclofenac Sodium | 54 | 17 |
| Amoxicillin | Amoxicillin | 53 | 37 |
| Glipizide | Glipizide | 53 | 19 |
| Naproxen | Naproxen | 53 | 17 |
| Baclofen | Baclofen | 51 | 14 |
| Synthroid | Levothyroxine Sodium | 50 | 14 |
| Terazosin Hcl | Terazosin Hcl | 49 | 15 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 48 | 42 |
| Trulicity | Dulaglutide | 48 | suppressed |
| Methylprednisolone | Methylprednisolone | 47 | 37 |
| Ondansetron Odt | Ondansetron | 47 | 15 |
| Ropinirole Hcl | Ropinirole Hcl | 47 | suppressed |
| Estradiol | Estradiol | 46 | 13 |
| Paroxetine Hcl | Paroxetine Hcl | 46 | 12 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 46 | 40 |
| Cephalexin | Cephalexin | 45 | 36 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 45 | 14 |
| Morphine Sulfate | Morphine Sulfate | 45 | suppressed |
| Clonazepam | Clonazepam | 44 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 44 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 43 | 11 |
| Valsartan | Valsartan | 43 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 41 | 11 |
| Glipizide Er | Glipizide | 41 | 11 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 41 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 41 | 41 |
| Januvia | Sitagliptin Phosphate | 40 | 11 |
| Clonidine Hcl | Clonidine Hcl | 38 | 13 |
| Meclizine Hcl | Meclizine Hcl | 38 | 13 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 38 | 14 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 38 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 37 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 37 | 30 |
| Eszopiclone | Eszopiclone | 36 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 36 | 29 |
| Azelastine Hcl | Azelastine Hcl | 35 | 13 |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 35 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 35 | suppressed |
| Nystatin | Nystatin | 35 | 16 |
| Carisoprodol | Carisoprodol | 34 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 34 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 34 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 33 | suppressed |
| Mounjaro | Tirzepatide | 31 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 31 | suppressed |
| Pregabalin | Pregabalin | 31 | 11 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 30 | suppressed |
| Verapamil Er | Verapamil Hcl | 30 | suppressed |
| Glimepiride | Glimepiride | 29 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 29 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 29 | suppressed |
| Metronidazole | Metronidazole | 29 | 24 |
| Ciclopirox | Ciclopirox | 28 | 13 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 28 | suppressed |
| Prolia | Denosumab | 28 | 16 |
| Xarelto | Rivaroxaban | 28 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 27 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 27 | 26 |
| Hydromorphone Hcl | Hydromorphone Hcl | 27 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 27 | 13 |
| Propranolol Hcl | Propranolol Hcl | 27 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 26 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 25 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 25 | suppressed |
| Fluconazole | Fluconazole | 25 | suppressed |
| Memantine Hcl | Memantine Hcl | 25 | 11 |
| Myrbetriq | Mirabegron | 25 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 25 | 13 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 25 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 25 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 24 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 23 | suppressed |
| Mupirocin | Mupirocin | 23 | 16 |
| Ozempic | Semaglutide | 23 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 23 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 23 | 11 |
| Ketoconazole | Ketoconazole | 22 | 14 |
| Nitroglycerin | Nitroglycerin | 22 | 11 |
| Phenobarbital | Phenobarbital | 22 | suppressed |
| Chlorthalidone | Chlorthalidone | 21 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 21 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 21 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 21 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 21 | suppressed |
| Lidocaine | Lidocaine | 21 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 21 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 21 | suppressed |
| Repatha Sureclick | Evolocumab | 21 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 21 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 20 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 20 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 20 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 20 | suppressed |
| Lamotrigine | Lamotrigine | 20 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 20 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Telmisartan | Telmisartan | 20 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 20 | suppressed |
| Rybelsus | Semaglutide | 19 | suppressed |
| Sucralfate | Sucralfate | 19 | suppressed |
| Torsemide | Torsemide | 19 | suppressed |
| Bumetanide | Bumetanide | 18 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 18 | suppressed |
| Ibu | Ibuprofen | 18 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 17 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 17 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 16 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 16 | suppressed |
| Testosterone | Testosterone | 16 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 15 | suppressed |
| Bupropion Xl | Bupropion Hcl | 15 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 15 | suppressed |
| Folic Acid | Folic Acid | 15 | suppressed |
| Humulin N | Insulin Nph Human Isophane | 15 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 15 | suppressed |
| Levetiracetam | Levetiracetam | 15 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 14 | suppressed |
| Humalog | Insulin Lispro | 14 | suppressed |
| Ramipril | Ramipril | 14 | suppressed |
| Tradjenta | Linagliptin | 14 | suppressed |
| Fenofibrate | Fenofibrate | 13 | suppressed |
| Metolazone | Metolazone | 13 | suppressed |
| Nifedipine Er | Nifedipine | 13 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Zaleplon | Zaleplon | 13 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 12 | suppressed |
| Armour Thyroid | Thyroid,pork | 12 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 12 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 12 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 12 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 12 | suppressed |
| Gemfibrozil | Gemfibrozil | 12 | suppressed |
| Irbesartan | Irbesartan | 12 | suppressed |
| Linzess | Linaclotide | 12 | suppressed |
| Nadolol | Nadolol | 12 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 12 | suppressed |
| Vimpat | Lacosamide | 12 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Carbamazepine | Carbamazepine | 11 | suppressed |
| Gemtesa | Vibegron | 11 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 11 | suppressed |
| Humulin R | Insulin Regular, Human | 11 | suppressed |
| Insulin Lispro | Insulin Lispro | 11 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 11 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 11 | suppressed |
| Novolin R | Insulin Regular, Human | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $101.40 · 4 records | Ferring Pharmaceuticals Inc. | ADSTILADRIN, GEMTESA, WATCHMAN FLX | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error